The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

Euro-Med Laboratories Phil., Inc.EURO

PSE Disclosure Form 17-18 - Other SEC Forms/Reports/Requirements

Form/Report Type	17-C
Report Period/Report Date	Mar 26, 2025

Description of the Disclosure

With reference to the Board Approval yesterday, 25 March 2025 on the list of Nominees approved by the Nomination Committee for election as members of the Board of Directors, enclosed herewith are the Certifications of Nominated Independent Directors for 2025-2026, to wit : Dr. William G. Padolina (Independent Director) Mr. Edwin D. Feist (Independent Director) Dr. Esperanza I. Cabral (Independent Director)